Abbott, North West London Pathology Partner For Diagnostics Products and Services

North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, and Abbott (No. 10 on the DiversityInc Top 50 Companies list) announced that they signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott’s Alinity ci and Alinity h series diagnostics instruments as well as their professional services and informatics solutions known as AlinIQ.


The contract was the subject of a detailed and competitive procurement process conducted by NWLP. Imperial College Healthcare NHS Trust, Chelsea and Westminster NHS Foundation Trust and the Hillingdon Hospitals NHS Foundation Trust consolidated their pathology services into NWLP earlier this year to better manage demand, standardize operations, improve value for money and make use of new technologies.

Stephen Snewin, managing director of NWLP, said: “NWLP aims to provide an innovative and sustainable pathology service which delivers outstanding quality for our patients and clinicians. After a highly competitive process involving multiple diagnostic equipment manufacturers, NWLP is extremely excited to be working with Abbott, which supports our vision of increased efficiency and transformation across six major sites in North West London using the latest technology.”

The partnership is expected to manage 26 million tests per year and currently holds 6 percent of the total pathology market in the UK.

“Abbott is delighted to provide NWLP with personalized Alinity and AlinIQ solutions to help them navigate the challenges of an evolving healthcare system,” said Mike Clayton, managing director, Northern Europe, for Abbott’s diagnostics business. “Through our partnership, we will equip NWLP to help maximize productivity, drive faster delivery of test results and provide the critical information needed for clinical decisions with the goal of helping the Trust improve patient outcomes.”

The hospitals included within this partnership are: Imperial College Healthcare NHS Trust, which comprises St Mary’s Hospital, Charing Cross Hospital, Hammersmith Hospital, Queen Charlotte and Chelsea Hospital and the Western Eye Hospital; Chelsea & Westminster Hospital Foundation Trust, which comprises Chelsea & Westminster Hospital and West Middlesex University Hospital; and Hillingdon Hospitals NHS Foundation Trust, which comprises Hillingdon Hospital and Mount Vernon Hospital.

Latest News

KPMG: Driving Inclusive Virtual Collaboration

Originally published on info.KPMG.us by Michele Meyer-Shipp As social distancing and virtual work have become our new normal, here are five suggestions to help ensure everyone on your team feels included and valued: Communicate often and in different ways. One of the challenges of working remotely is feeling isolated, especially if you’re…

Calm App Available to Kaiser Permanente Members at No Cost

Originally published on KaiserPermanente.org. The meditation and sleep app, part of Kaiser Permanente’s self-care portfolio, supports people looking for ways to manage stress and build resilience, particularly in uncertain times.  OAKLAND, Calif., May 19, 2020 — Kaiser Permanente announced it has added Calm, a leading app for mindfulness meditation and…

Dow Collaborates with Multiple Partners to Develop and Donate Level 2 Medical Isolation Gowns

Originally posted on Dow.com Collaboration included Magna International, Inc., 3M, Cadillac Products Packaging Company, DuPont, Fitesa, Landaal Packaging Systems, Plastixx FFS Technologies, Shurtape and Volkswagen 100,000 isolation gowns to be donated to healthcare professionals For healthcare professionals battling the COVID-19 pandemic, isolation gowns are among the most used and needed…

Hershey Stockholders Elect Victor L. Crawford To Company Board

Originally published on thehersheycompany.com. HERSHEY, Pa., May 18, 2020 (GLOBE NEWSWIRE) — The Hershey Company (NYSE: HSY) today announced the election of Victor L. Crawford to its board of directors. Crawford is the newest Hershey board member and was elected at the company’s recent Annual Stockholder’s Meeting. Victor L. Crawford Crawford brings deep executive and leadership experience to…

Novartis Discusses Navigating Cancer During COVID-19

Originally published on LinkedIn. Watch the recent discussion between Susanne Schaffert, PhD and President of Novartis Oncology and Pat Garcia-Gonzalez, Founder and CEO of The Max Foundation, a patient advocacy group, to learn how they are helping people living with CML stay safe and get the support and treatment they need.

Nielsen Publishes Asian American Consumer Report for Asian American and Pacific Islander Heritage Month

Originally published on nielsen.com. REPRESENTATION MATTERS Asian Americans are a driving force in the U.S., both as cultural influencers and powerful consumers. Your representation within the products and media you love begins with data. At Nielsen, we provide a cultural narrative for diverse communities through our research. Below you will…